Mitigating VOD Risk in Patients Treated for Relapsed/Refractory B-cell Precursor Acute Lymphoblastic Leukemia (R/R ALL)
Mitigating Veno-occlusive Disease Risk in Patients Treated for Relapsed/Refractory B-cell Precursor ALL
Digital FAQVeno-occlusive disease (VOD) is a life-threatening condition associated with treatment of relapsed/refractory B-cell precursor acute lymphoblastic leukemia (R/R ALL). Early recognition and management are paramount to recovery. This self-directed education was designed for diverse members of the interdisciplinary care team that treat or may encounter patients with R/R ALL who are at risk for VOD. Expert commentary from Partow Kebriaei, MD provides answers to common questions faced by clinicians when diagnosing and managing VOD.
Faculty: Partow Kebriaei, MD
Release Date:
Expiration Date: December 02, 2023
CME/CE is no longer available for this activity